Tablet
TONFONRIN TABLETS 5MG
Summary
TONFONRIN TABLETS 5MG — Tablet containing prednisolone. Hong Kong Registration No. HK-66020. Certificate Holder: SWISS PHARMACEUTICAL (HK) COMPANY LIMITED. Date of Registration: 18 Dec, 2018.
Product NameTONFONRIN TABLETS 5MG
Registration No.HK-66020
Certificate HolderSWISS PHARMACEUTICAL (HK) COMPANY LIMITED
Holder AddressFLAT/RM 505 BLK 2 5/F, CHEUNG SHA WAN PLAZA, 833, CHEUNG SHA WAN ROAD, NEW TERRITORIES
Ingredientsprednisolone
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration18 Dec, 2018
ATC codesA01AC04, A07EA01, C05AA04, D07AA03, D07XA02, H02AB06, R01AD02, S01BA04, S01CB02, S02BA03, S03BA02
ATC Classification
ATC level 1
A Alimentary Tract and Metabolism / C Cardiovascular System / D Dermatologicals / H Systemic Hormonal Preparations / R Respiratory System / S Sensory Organs
All ATC groupsA01, A07, C05, D07, H02, R01, S01, S02, S03
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。